Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec:124:598-605.
doi: 10.1016/j.sleep.2024.09.038. Epub 2024 Oct 5.

Delphi consensus recommendations for the management of chronic insomnia in Canada

Charles M Morin  1 , Atul Khullar  2 , Rebecca Robillard  3 , Alex Desautels  4 , Michael S B Mak  5 , Thien Thanh Dang-Vu  6 , Walter Chow  7 , Jeff Habert  8 , Serge Lessard  9 , Lemore Alima  10 , Najib T Ayas  11 , James MacFarlane  12 , Tetyana Kendzerska  13 , Elliott K Lee  14 , Colleen E Carney  15
Affiliations
Free article

Delphi consensus recommendations for the management of chronic insomnia in Canada

Charles M Morin et al. Sleep Med. 2024 Dec.
Free article

Abstract

Objective: The lack of current Canadian practice guidelines for the management of insomnia poses a challenge for healthcare providers (HCP) in selecting the appropriate treatment options. This study aimed to establish expert consensus recommendations for the management of chronic insomnia in Canada.

Composition of the committee: Sixteen multidisciplinary experts in sleep medicine and insomnia across Canada developed consensus recommendations based on their knowledge of the literature and their practical experience.

Methods: The consensus recommendations were developed through a Delphi method. Consensus was reached if at least 75 % of the voting participants "agreed" or "strongly agreed" with the corresponding statements. The quality of supporting evidence was rated using a GRADE rating system.

Report: Among 37 recommendations that reached consensus for the management of chronic insomnia, the experts recommend and agree that.

Conclusion: These consensus recommendations highlight the need to increase awareness, capacity for, and access to CBT-I; integrate newly approved pharmacotherapy; reduce both self-medication and medications with limited evidence or low risk/benefit ratio.

Keywords: Canadian practice; Chronic insomnia management; Consensus recommendations; Family practice/general practice/primary care.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alex Desautels reports operating grants: CHIR, AASM, FRQ-S, HSF; research contracts: Eisai and Takeda; advisory boards: Eisai, Paladin Labs and UCB; speaking engagements: Eisai, Jazz Pharma and Paladin Labs. Jeffrey Habert reports Advisory Board/Speaker: Boehringer, Eli- Lilly, Elvium, Takeda, Bausch, Astra-Zeneca, Novartis, Lundbeck, Novo-Nordisk, Janssen, Eisai, HLS, Otsuka, Idorsia Pfizer, Amgen, Abbvie, GSK, Bayer, Valeo; Scientific Committees/Speaker: MDBriefcase, Liv, MedPlan, Master Clinician Alliance, Academy, Bridge, PeerVoice, Seacourses, Thrombosis Canada, Meducom, CHRC, CPD Network, CTC, STA, CCRN, Telus Health, EOCI, AgenceUnik, Humber Hospital, ABPHE, CSEM. Atul Kular reports serving on advisory board/speaker for Elvium, Bausch, Lundbeck, Eisai, Otsuka, Idorsia, Abbvie, Jazz; scientific committees/speaker for ICPDHC CPD Network, CCRN, and Telus Health. Serge Lessard reports Advisory Board/Speaker: AbbVie, Biron, Bausch, Eisai, Elvium, Idorsia, Jazz, Takeda, Lundbeck, Janssen, Otsuka, Sunovi; Scientific Committees/Speaker: MD Briefcase, Liv, MedPlan, CCRN; research grants from: Allergan, Janssen. Michael S.B. Mak reports education grants, consulting and speaking fees with Eisai Inc; education grants and speaking fees with Paladin; education grants, consulting and speaking fees with Jazz Pharmaceuticals; education grants and stocks with ResMed; consulting and speaking fees with Idorsia. Charles M. Morin reports funding from the Canadian Institutes of Health Research, Fonds de recherche du Quebec, National Institutes of Health; consulting for Eisai, Idorsia, Haleon; royalties from Mapi Research Trust.

References